<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Interactive Neuroanatomy Platform</title>
  <style>
    body {
      font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
      background: linear-gradient(to bottom right, #87CEFA, #FF00FF, #800080);
    }

    .container {
      display: flex;
    }

    .left-panel {
      flex: 2;
      padding: 20px;
    }

    .right-panel {
      flex: 1;
      padding: 20px;
    }

    .brain-image {
      width: 70%; /* Ensure the image covers the left two-thirds of the screen */
    }

    #pathway-select {
      margin-top: 20px;
      padding: 10px;
      font-size: 16px;
      border-radius: 5px;
    }

    #pathway-title {
      font-size: 30px;
      font-weight: bold;
    }

    #anatomical-structures {
      font-size: 20px;
      list-style-type: none;
    }
  </style>
</head>
<body>
  <div class="container">
    <div class="left-panel">
      <img src="Brain_default.png" alt="Brain Representation" class="brain-image">
      <select id="pathway-select">
        <option value="default" selected>Select Pathway</option>
        <option value="reward">Reward Pathway</option>
        <option value="limbic">Limbic System</option>
        <option value="language">Language Pathways</option>
        <option value="vision">Vision Pathways</option>
        <option value="mesocortical">Mesocortical Pathway</option>
        <option value="mesostriatal">Mesostriatal Pathway</option>
        <option value="tuberoinfundibular">Tuberoinfundibular Pathway</option>
        <option value="mesolimbic">Mesolimbic Pathway</option>
        <option value="fear conditioning">Fear Conditioning Pathway</option>
        <option value="brodmann">Brodmann Areas</option>
      </select>
    </div>
    <div class="right-panel">
      <h2 id="pathway-title">Select a Pathway</h2>
      <div id="anatomical-structures">
        <!-- Anatomical structures will be listed here -->
      </div>
    </div>
  </div>
  <script>
    // Function to update the list of anatomical structures
    function updateAnatomicalStructures(pathway) {
      var structures = [];
      var structuresList = document.getElementById("anatomical-structures");
      var pathwayTitle = document.getElementById("pathway-title");

      // Clear previous contents
      structuresList.innerHTML = "";

      // Populate the list with the structures based on the selected pathway
      switch (pathway) {
        case "default":
          structures = [
            {
              name: "Frontal Lobe",
              description: "Involved in executive functions such as decision making, planning, and social behavior. Lesions may cause deficits in executive functions, personality changes, and impaired social behavior.",
              lesions: "Lesions in the frontal lobe may result from traumatic brain injury, stroke, or neurodegenerative diseases such as frontotemporal dementia.",
              pharmacologicalAgents: "Pharmacological agents targeting this area include selective serotonin reuptake inhibitors (SSRIs) for mood disorders and stimulants for attention deficit hyperactivity disorder (ADHD).",
            },
            // Add more structures as needed
          ];
          break;
        case "reward":
      structures = [
        {
          name: "Nucleus Accumbens",
          description: "Part of the reward pathway, involved in pleasure, reinforcement, and motivation. Lesions or dysfunction may lead to anhedonia, addiction, or depression.",
          lesions: "Lesions in the nucleus accumbens may result from chronic drug use, neurodegenerative diseases, or trauma.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include dopamine agonists or antagonists for addiction treatment and antidepressants for mood disorders.",
        },
        {
          name: "Ventral Tegmental Area (VTA)",
          description: "Produces dopamine, a key neurotransmitter in the reward system. Dysfunction may lead to depression or addiction.",
          lesions: "Lesions or dysfunction in the ventral tegmental area may result from chronic stress, drug abuse, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include dopamine reuptake inhibitors for depression and antipsychotics for psychosis.",
        },
        // Add more structures as needed
      ];
      break;
    case "limbic":
      structures = [
        {
          name: "Amygdala",
          description: "Key in processing emotions, particularly fear and aggression. Lesions may result in deficits in emotional processing and regulation.",
          lesions: "Lesions in the amygdala may result from traumatic brain injury, epilepsy, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include anxiolytics such as benzodiazepines for anxiety disorders.",
        },
        {
          name: "Hippocampus",
          description: "Crucial for memory formation and spatial navigation. Lesions may result in deficits in memory consolidation and spatial orientation.",
          lesions: "Lesions in the hippocampus may result from stroke, epilepsy, or neurodegenerative diseases such as Alzheimer's disease.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include acetylcholinesterase inhibitors for Alzheimer's disease.",
        },
        // Add more structures as needed
      ];
      break;
    case "language":
      structures = [
        {
          name: "Broca's Area",
          description: "Responsible for speech production and language processing. Lesions may result in expressive aphasia characterized by difficulty in producing speech.",
          lesions: "Lesions in Broca's area may result from stroke, traumatic brain injury, or tumors.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include antiepileptic drugs for seizures and antidepressants for mood disorders.",
        },
        {
          name: "Wernicke's Area",
          description: "Involved in language comprehension and understanding. Lesions may result in receptive aphasia characterized by difficulty in understanding speech.",
          lesions: "Lesions in Wernicke's area may result from stroke, traumatic brain injury, or tumors affecting the language centers.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include antipsychotics for psychosis and anticonvulsants for seizures.",
        },
        // Add more structures as needed
      ];
      break;
    case "vision":
      structures = [
        {
          name: "Primary Visual Cortex (V1)",
          description: "Processes visual information from the eyes and is responsible for basic visual perception. Lesions may cause visual field defects and visual hallucinations.",
          lesions: "Lesions in the primary visual cortex may result from stroke, head trauma, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include antiepileptic drugs for seizures and antipsychotics for visual hallucinations.",
        },
        {
          name: "Optic Nerve",
          description: "Transmits visual information from the retina to the brain. Lesions may result in visual field defects and vision loss.",
          lesions: "Lesions in the optic nerve may result from optic neuritis, glaucoma, or trauma.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include corticosteroids for optic neuritis and antiglaucoma medications for glaucoma.",
        },
        // Add more structures as needed
      ];
      break;
    case "mesocortical":
      structures = [
        {
          name: "Prefrontal Cortex",
          description: "Involved in executive functions, such as planning, decision-making, and impulse control. Lesions may result in deficits in cognition, personality, and social behavior.",
          lesions: "Lesions in the prefrontal cortex may result from traumatic brain injury, stroke, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include dopamine agonists for Parkinson's disease and antipsychotics for schizophrenia.",
        },
        {
          name: "Anterior Cingulate Cortex (ACC)",
          description: "Part of the limbic system, involved in emotions, cognitive processing, and pain perception. Lesions may result in deficits in emotion regulation and cognitive control.",
          lesions: "Lesions in the anterior cingulate cortex may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include selective serotonin reuptake inhibitors (SSRIs) for depression and analgesics for pain management.",
        },
        // Add more structures as needed
      ];
      break;
    case "mesostriatal":
      structures = [
        {
          name: "Substantia Nigra",
          description: "Produces dopamine and is involved in reward, movement, and addiction. Lesions may result in motor deficits, such as bradykinesia and rigidity.",
          lesions: "Lesions in the substantia nigra may result from Parkinson's disease, stroke, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include dopamine agonists for Parkinson's disease and antipsychotics for psychosis.",
        },
        {
          name: "Striatum",
          description: "Involved in motor control, reward processing, and learning. Lesions may result in motor deficits and cognitive impairments.",
          lesions: "Lesions in the striatum may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include dopamine agonists for Parkinson's disease and antipsychotics for psychosis.",
        },
        // Add more structures as needed
      ];
      break;
    case "tuberoinfundibular":
      structures = [
        {
          name: "Median Eminence",
          description: "Part of the hypothalamus, involved in neuroendocrine regulation. Lesions may result in hormonal imbalances, such as hypopituitarism.",
          lesions: "Lesions in the median eminence may result from tumors, trauma, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include dopamine agonists for prolactinoma and growth hormone for growth hormone deficiency.",
        },
        {
          name: "Pituitary Gland",
          description: "Master endocrine gland, involved in hormone secretion and regulation. Lesions may result in hormonal imbalances and endocrine disorders.",
          lesions: "Lesions in the pituitary gland may result from tumors, ischemia, or inflammation.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include glucocorticoids for adrenal insufficiency and thyroid hormone replacement for hypothyroidism.",
        },
        // Add more structures as needed
      ];
      break;
    case "mesolimbic":
      structures = [
        {
          name: "Ventral Tegmental Area (VTA)",
          description: "Produces dopamine, a key neurotransmitter in the reward system. Dysfunction may lead to depression or addiction.",
          lesions: "Lesions or dysfunction in the ventral tegmental area may result from chronic stress, drug abuse, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include dopamine reuptake inhibitors for depression and antipsychotics for psychosis.",
        },
        {
          name: "Nucleus Accumbens",
          description: "Part of the reward pathway, involved in pleasure, reinforcement, and motivation. Lesions or dysfunction may lead to anhedonia, addiction, or depression.",
          lesions: "Lesions in the nucleus accumbens may result from chronic drug use, neurodegenerative diseases, or trauma.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include dopamine agonists or antagonists for addiction treatment and antidepressants for mood disorders.",
        },
        // Add more structures as needed
      ];
      break;
    case "fear conditioning":
      structures = [
        {
          name: "Amygdala",
          description: "Key in processing emotions, particularly fear and aggression. Lesions may result in deficits in emotional processing and regulation.",
          lesions: "Lesions in the amygdala may result from traumatic brain injury, epilepsy, or neurodegenerative diseases.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include anxiolytics such as benzodiazepines for anxiety disorders.",
        },
        {
          name: "Hippocampus",
          description: "Crucial for memory formation and spatial navigation. Lesions may result in deficits in memory consolidation and spatial orientation.",
          lesions: "Lesions in the hippocampus may result from stroke, epilepsy, or neurodegenerative diseases such as Alzheimer's disease.",
          pharmacologicalAgents: "Pharmacological agents targeting this area include acetylcholinesterase inhibitors for Alzheimer's disease.",
        },
        // Add more structures as needed
      ];
     case "brodmann":
  structures = [
    {
      name: "Brodmann Area 1 (Primary Somatosensory Cortex)",
      description: "Receives and processes tactile sensory information from the body, including touch, pressure, vibration, and proprioception (awareness of body position).",
      lesions: "Lesions in Brodmann Area 1 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 2, 3 (Primary Somatosensory Cortex)",
      description: "Receives and processes tactile sensory information from the body, including touch, pressure, vibration, and proprioception (awareness of body position).",
      lesions: "Lesions in Brodmann Areas 2 and 3 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 4 (Primary Motor Cortex)",
      description: "Initiates and controls voluntary movements of skeletal muscles.",
      lesions: "Lesions in Brodmann Area 4 may result from stroke, traumatic brain injury, or tumors.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 5, 7 (Somatosensory Association Cortex)",
      description: "Integrates and processes sensory information received from primary somatosensory cortex, contributing to perception and recognition of tactile stimuli and spatial orientation.",
      lesions: "Lesions in Brodmann Areas 5 and 7 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 6 (Premotor Cortex)",
      description: "Involved in planning and coordinating movements, including the organization of complex, purposeful actions.",
      lesions: "Lesions in Brodmann Area 6 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 8 (Frontal Eye Field)",
      description: "Plays a role in the voluntary control of eye movements, particularly saccadic eye movements.",
      lesions: "Lesions in Brodmann Area 8 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 9, 10 (Dorsolateral Prefrontal Cortex)",
      description: "Associated with executive functions, such as decision-making, planning, problem-solving, working memory, and cognitive control.",
      lesions: "Lesions in Brodmann Areas 9 and 10 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 11, 12 (Orbitofrontal Cortex)",
      description: "Involved in emotional regulation, social behavior, decision-making, and reward processing.",
      lesions: "Lesions in Brodmann Areas 11 and 12 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 17 (Primary Visual Cortex, V1)",
      description: "Processes visual information received from the retina, including basic visual features such as orientation, motion, and color.",
      lesions: "Lesions in Brodmann Area 17 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 18, 19 (Secondary Visual Cortex, V2, V3, V4)",
      description: "Involved in higher-level processing of visual information, such as object recognition, visual perception, and interpretation of visual scenes.",
      lesions: "Lesions in Brodmann Areas 18 and 19 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 22 (Superior Temporal Gyrus, Wernicke's Area)",
      description: "Plays a role in language comprehension, particularly the understanding of spoken language.",
      lesions: "Lesions in Brodmann Area 22 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 41, 42 (Primary Auditory Cortex)",
      description: "Processes auditory information received from the ears, including sound frequency, intensity, and localization.",
      lesions: "Lesions in Brodmann Areas 41 and 42 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 44, 45 (Inferior Frontal Gyrus, Broca's Area)",
      description: "Involved in speech production, specifically the coordination of speech muscles and articulation.",
      lesions: "Lesions in Brodmann Areas 44 and 45 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 46 (Dorsolateral Prefrontal Cortex)",
      description: "Associated with working memory, attention, and cognitive control functions.",
      lesions: "Lesions in Brodmann Area 46 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 24, 25 (Anterior Cingulate Cortex)",
      description: "Involved in emotion regulation, decision-making, and error detection.",
      lesions: "Lesions in Brodmann Areas 24 and 25 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 31, 32 (Dorsal Anterior Cingulate Cortex)",
      description: "Associated with cognitive control, attention, and emotional processing.",
      lesions: "Lesions in Brodmann Areas 31 and 32 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 34, 35 (Perirhinal Cortex)",
      description: "Involved in memory encoding, recognition memory, and object perception.",
      lesions: "Lesions in Brodmann Areas 34 and 35 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 39, 40 (Angular Gyrus, Supramarginal Gyrus)",
      description: "Associated with language processing, semantic memory, and numerical cognition.",
      lesions: "Lesions in Brodmann Areas 39 and 40 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 46, 47 (Frontal Association Cortex)",
      description: "Involved in higher-order cognitive functions, including working memory, decision-making, and attention.",
      lesions: "Lesions in Brodmann Areas 46 and 47 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 52 (Parainsular Cortex)",
      description: "Plays a role in visceral and autonomic functions, including perception of internal bodily sensations and emotional processing.",
      lesions: "Lesions in Brodmann Area 52 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
    {
      name: "Brodmann Area 69, 70 (Retrosplenial Cortex)",
      description: "Involved in spatial memory, navigation, and integration of sensory information for spatial orientation.",
      lesions: "Lesions in Brodmann Areas 69 and 70 may result from stroke, traumatic brain injury, or neurodegenerative diseases.",
      pharmacologicalAgents: "No specific pharmacological agents target this area directly.",
    },
  ];
       
      break;
    default:
      structures = ["Select a pathway to view structures"];
      }

      // Set the pathway title
      pathwayTitle.textContent = pathway.charAt(0).toUpperCase() + pathway.slice(1) + " Pathway";

      // Populate the list with the structures
      structures.forEach(function(structure) {
        var listItem = document.createElement("li");
        var structureName = document.createElement("span");
        var structureDescription = document.createElement("span");
        var structureLesions = document.createElement("span");
        var structurePharmacologicalAgents = document.createElement("span");

        structureName.textContent = structure.name;
        structureName.style.fontWeight = "bold";
        structureDescription.textContent = structure.description;
        structureLesions.textContent = "Lesions: " + structure.lesions;
        structurePharmacologicalAgents.textContent = "Pharmacological Agents: " + structure.pharmacologicalAgents;

        listItem.appendChild(structureName);
        listItem.appendChild(document.createElement("br")); // Add line break for spacing
        listItem.appendChild(structureDescription);
        listItem.appendChild(document.createElement("br")); // Add line break for spacing
        listItem.appendChild(structureLesions);
        listItem.appendChild(document.createElement("br")); // Add line break for spacing
        listItem.appendChild(structurePharmacologicalAgents);

        structuresList.appendChild(listItem);
      });
    }

    // Add an event listener to the dropdown menu
    document.getElementById("pathway-select").addEventListener("change", function() {
        // Get the selected pathway
        var selectedPathway = this.value;
        // Call the function to update anatomical structures with the selected pathway
        updateAnatomicalStructures(selectedPathway);
    });

    // Call the function initially with the default pathway
    updateAnatomicalStructures("default");
  </script>
</body>
</html>
